Return to the previous page

The Measures for the Registration and Filing Management of Cosmetics shall come into force on May 1, 2021.

Jan 25,2021

Summary: The Measures for the Registration and Filing of Cosmetics were reviewed and adopted at the 14th Bureau Meeting of the State Administration for Market Regulation on December 31, 2020. They are hereby promulgated and shall enter into force on May 1, 2021.
The Measures for the Registration and Filing Management of Cosmetics shall come into force on May 1, 2021.

Order of the State Administration for Market Regulation

No. 35

  The Measures for the Registration and Filing Management of Cosmetics were reviewed and adopted at the 14th Bureau Meeting of the State Administration for Market Regulation on December 31, 2020, and are hereby promulgated, entering into force on May 1, 2021.

Director Zhang, Engineer Zhang

January 7, 2021

Administrative Measures for the Registration and Filing of Cosmetics

(Promulgated on January 7, 2021, by Order No. 35 of the State Administration for Market Regulation)

  Chapter I General Provisions

  Article 1: In order to standardize the registration and filing of cosmetics and ensure their quality and safety, these Measures are formulated in accordance with the Regulations on the Supervision and Administration of Cosmetics.

  Article 2 This Measures shall apply to the registration, filing, and supervisory administration of cosmetics and new cosmetic ingredients within the territory of the People’s Republic of China.

  Article 3. Registration of cosmetics and new cosmetic ingredients refers to the process whereby the applicant submits a registration application in accordance with the statutory procedures and requirements, and the drug regulatory authority reviews the safety and quality controllability of the cosmetics or new cosmetic ingredients subject to registration, and decides whether to approve the application.

  The filing of cosmetics and new cosmetic ingredients refers to the process whereby the filer, in accordance with statutory procedures and requirements, submits documentation demonstrating the safety and controllable quality of the cosmetics or new cosmetic ingredients, and the drug regulatory authority archives such submissions for record‑keeping purposes.

  Article 4: The State shall implement a registration system for special cosmetics and new cosmetic ingredients with a higher risk level, and a filing system for ordinary cosmetics and other new cosmetic ingredients.

  Article 5 The National Medical Products Administration is responsible for the registration and filing management of special cosmetics, imported ordinary cosmetics, and new cosmetic ingredients, and it shall provide guidance and oversight over the cosmetic filing-related work undertaken by the medical products administration departments of provinces, autonomous regions, and municipalities directly under the central government. The National Medical Products Administration may entrust the medical products administration departments of provinces, autonomous regions, and municipalities directly under the central government that possess the requisite capabilities to carry out the filing management of imported ordinary cosmetics.

  The Cosmetic Technical Review Agency of the National Medical Products Administration (hereinafter referred to as the Technical Review Agency) is responsible for conducting technical reviews of applications for the registration of special cosmetics and new cosmetic ingredients, performing technical verification of documentation submitted for the filing of imported ordinary cosmetics and new cosmetic ingredients, and evaluating reports on the use and safety of new cosmetic ingredients.

  The National Medical Products Administration’s administrative service agencies (hereinafter referred to as the acceptance agencies), review and inspection agencies, adverse reaction monitoring agencies, information management agencies, and other specialized technical institutions are responsible for tasks such as registration acceptance, on-site inspections, adverse reaction monitoring, and information system development and management—activities essential to the registration and filing management of cosmetics.

  Article 6: The drug regulatory authorities of provinces, autonomous regions, and municipalities directly under the central government are responsible for the filing and management of domestically produced ordinary cosmetics within their respective administrative areas. Within the scope of their delegated authority, they shall carry out the filing and management of imported ordinary cosmetics in the name of the National Medical Products Administration, and assist in conducting on-site inspections for the registration of special‑purpose cosmetics, among other related tasks.

  Article 7: Registrants and filers of cosmetics and new cosmetic ingredients shall, in accordance with the law, fulfill their obligations regarding product registration and filing, and shall be responsible for the quality and safety of cosmetics and new cosmetic ingredients.

  When applying for registration or filing of cosmetics or new cosmetic ingredients, the registrant or filer shall comply with the requirements of relevant laws, administrative regulations, mandatory national standards, and technical specifications, and shall be responsible for the authenticity and scientific validity of the submitted materials.

  Article 8: Where the registrant or filer is located outside China, it shall designate a corporate legal entity within China as the domestic responsible party. The domestic responsible party shall fulfill the following obligations:

  (1) Handle the registration and filing of cosmetics and new cosmetic ingredients in the name of the registrant or filer;

  (2) Assist registrants and filers in conducting adverse reaction monitoring for cosmetics, as well as safety monitoring and reporting of new cosmetic ingredients.

  (3) Assist registrants and filers in carrying out recalls of cosmetics and new cosmetic ingredients;

  (4) In accordance with the agreement with the registrant or filer, assume the corresponding responsibilities for the quality and safety of cosmetics and new cosmetic ingredients placed on the domestic market;

  (5) Cooperate with the supervision and inspection activities of the drug regulatory authorities.

  Article 9: Within five working days from the date of approval of registration or completion of filing for cosmetics and new cosmetic ingredients, the drug regulatory authority shall publicly disclose relevant information on the registration and filing management of cosmetics and new cosmetic ingredients, making it available for public access.

  Article 10 The National Medical Products Administration shall strengthen information technology development to provide streamlined services for registrants and filers.

  Cosmetic product registrants and notifiers, as well as new cosmetic ingredient registrants and notifiers, shall, in accordance with the relevant provisions, submit registration applications or file notifications through the Cosmetic and New Cosmetic Ingredient Registration and Filing Information Service Platform (hereinafter referred to as the “Information Service Platform”).

  The National Medical Products Administration has established a catalog of cosmetic ingredients currently in use, which is updated promptly and made publicly available to facilitate inquiries by enterprises.

  Article 11: The drug regulatory authority may establish an expert advisory mechanism to solicit expert opinions on critical issues arising during technical review, on-site inspections, and supervisory inspections, thereby leveraging the technical expertise of experts.

  Chapter 2: Registration and Filing Management of New Cosmetic Ingredients

  Section 1: Registration and Filing of New Cosmetic Ingredients

  Article 12: Natural or synthetic ingredients that are used for the first time in cosmetics within the territory of China shall be deemed new cosmetic ingredients.

  Where the intended use, safe usage levels, or other aspects of a cosmetic ingredient already in use are modified, an application for registration or filing shall be submitted in accordance with the requirements for the registration and filing of new ingredients.

  Article 13. Applications for the registration of new cosmetic ingredients with functions such as corrosion protection, sun protection, coloring, hair dyeing, or spot‑removal and whitening shall be submitted in accordance with the requirements of the National Medical Products Administration. The accepting authority shall, within five working days from the date of receipt of the application, complete a formal review of the submitted materials and, depending on the circumstances, take one of the following actions:

  (1) If the matter for which application is made does not, according to law, require registration, a decision shall be made not to accept the application, and a Notice of Non-Acceptance shall be issued.

  (2) If the matter submitted for application does not fall within the purview of the National Medical Products Administration in accordance with the law, a decision shall be made to reject the application, a Notice of Non-Acceptance shall be issued, and the applicant shall be informed that they may submit their application to the relevant administrative authority.

  (3) If the application materials are incomplete or do not conform to the prescribed format, a notice of amendment shall be issued, informing the applicant in a single instance of all items requiring supplementation. If no such notice is issued within the prescribed time limit, the application shall be deemed accepted as of the date of receipt of the application materials.

  (4) Where the application materials are complete and comply with the prescribed formal requirements, or where the applicant has submitted all supplementary materials as required, the registration application shall be accepted and a notice of acceptance shall be issued.

  The accepting authority shall, within three working days of accepting the registration application, forward the application materials to the technical review agency.

  Article 14: The technical review agency shall, within ninety working days from the date of receipt of the application materials, organize and conduct the technical review in accordance with the requirements for technical review, and shall take the following actions depending on the circumstances:

  (1) If the application materials are true and complete, and can demonstrate the safety of the raw materials and their controllable quality, and comply with the requirements of laws, administrative regulations, mandatory national standards, and technical specifications, the technical review agency shall issue a conclusion approving the technical review.

  (2) If the application materials are false and fail to demonstrate the safety of the raw materials or the controllability of their quality, or if they do not comply with the requirements of laws, administrative regulations, mandatory national standards, and technical specifications, the technical review agency shall issue a conclusion that the technical review has not been passed.

  (3) Where supplementary information is required from the applicant, all such requirements shall be communicated in a single notice. The applicant shall submit all requested supplementary materials in one submission within 90 working days; upon receipt of the supplementary materials, the technical review agency shall restart the review period. If the supplementary materials are not submitted within the prescribed time limit, the technical review agency shall issue a conclusion that the technical review has not been passed.

  Article 15: Where the technical review concludes that the application does not meet the requirements, the technical review body shall notify the applicant and provide a detailed explanation of the reasons. If the applicant disagrees, they may, within twenty working days from the date of receipt of the technical review conclusion, request a re-examination. The scope of the re-examination shall be limited to the original matters submitted in the application and the supporting documentation.

  The technical review agency shall render a review conclusion within 30 working days from the date of receipt of the request for reconsideration.

  Article 16: Within twenty working days from the date of receipt of the technical review conclusion, the National Medical Products Administration shall review the legality, compliance, and completeness of the technical review procedures and conclusions, and make a decision on whether to grant registration.

  The accepting authority shall, within ten working days from the date on which the National Medical Products Administration makes its administrative approval decision, issue to the applicant either a registration certificate for a new cosmetic ingredient or a decision of non-registration.

  Article 17: Prior to the technical review body rendering its technical review conclusion, the applicant may withdraw the registration application. During the technical review process, if there are indications of the submission of false information or if safety concerns are identified with a new cosmetic ingredient, the technical review body shall handle such matters in accordance with the law, and the applicant shall not be permitted to withdraw the registration application.

  Article 18: The registrant of a new cosmetic ingredient shall be deemed to have completed the registration upon submission of the required documentation in accordance with the requirements of the National Medical Products Administration.

  Section 2: Safety Monitoring and Reporting

  Article 19: Newly developed cosmetic ingredients that have been registered or filed shall be subject to a safety monitoring system. The duration of such safety monitoring shall be three years, commencing from the date on which the cosmetic product containing the new ingredient first obtains registration or completes filing.

  Article 20: During the period of safety monitoring, the registrant or filer of a new cosmetic ingredient may use that ingredient to manufacture cosmetics.

  When a cosmetic product registrant or filer uses a new cosmetic ingredient to manufacture cosmetics, the relevant registration application or filing shall, through the information service platform, undergo associated confirmation by the registrant or filer of the new cosmetic ingredient.

  Article 21: The registrant or filer of a new cosmetic ingredient shall establish a post‑market safety risk monitoring and evaluation system, conduct follow‑up studies on the safety of the new cosmetic ingredient, and continuously monitor and evaluate its use and safety profile.

  The registrant or filer of a new cosmetic ingredient shall, within 30 working days prior to the completion of each one-year period of safety monitoring, compile and analyze data on the use and safety of the new cosmetic ingredient, and submit an annual report to the National Medical Products Administration.

  Article 22: Where any of the following circumstances are identified, the registrant or filer of a new cosmetic ingredient shall immediately conduct relevant studies and report to the technical review authority:

  (1) Where other countries (or regions) have identified suspected serious adverse reactions to cosmetics or cluster adverse reaction events attributable to the use of similar raw materials;

  (2) Where the laws, regulations, or standards of other countries (or regions) impose stricter usage requirements, additional usage restrictions, or prohibitions on similar ingredients;

  (3) Other circumstances related to the safety of new cosmetic ingredients.

  Where evidence indicates that a new cosmetic ingredient poses safety concerns, the registrant or filer of the new cosmetic ingredient shall promptly take measures to mitigate risks and report to the technical review authority.

  Article 23: Cosmetic product registrants and filers who use new cosmetic ingredients in the production of cosmetic products shall promptly provide feedback to the registrant or filer of such new ingredients regarding the usage and safety status of those ingredients.

  When adverse reactions or safety concerns related to a new cosmetic ingredient arise, the cosmetic product registrant or filer shall promptly implement measures to mitigate risks, notify the registrant or filer of the new cosmetic ingredient, and report to the drug regulatory authority of the province, autonomous region, or municipality directly under the central government where the product is manufactured, in accordance with applicable regulations.

  Article 24: Upon receiving reports of adverse reactions or safety concerns related to cosmetics that contain new cosmetic ingredients, the drug regulatory authorities of provinces, autonomous regions, and municipalities directly under the central government shall conduct a thorough assessment and analysis. If they determine that such new cosmetic ingredients may pose safety risks, including the potential to cause harm to human health, they shall, in accordance with relevant regulations, implement measures to control these risks and promptly notify the technical review agency.

  Article 25: Upon receiving feedback or reports from the drug regulatory authorities of provinces, autonomous regions, or municipalities directly under the central government, or from the registrants or filers of new cosmetic ingredients, the technical review agency shall, in conjunction with the annual statistical analysis of adverse reactions conducted by the adverse reaction monitoring institution, conduct an assessment. If it determines that the safety risks can be eliminated by adjusting the technical requirements for the new cosmetic ingredient, it may submit recommendations for such adjustments to the National Medical Products Administration; if it identifies safety concerns, it shall request the NMPA to revoke the registration or cancel the filing. The NMPA shall render a decision promptly.

  Article 26: Three years after the expiration of the safety monitoring period for a new cosmetic ingredient, the technical review agency shall submit to the National Medical Products Administration its opinion on whether the new cosmetic ingredient meets the safety requirements.

  For new cosmetic ingredients that pose safety concerns, the National Medical Products Administration shall revoke their registration or cancel their filing; for those that have not raised any safety issues, the Administration shall include them in the Catalogue of Used Cosmetic Ingredients.

  Article 27: During the safety monitoring period, if a new cosmetic ingredient is ordered to be suspended from use, the cosmetic product registrant or filer shall simultaneously suspend the production and marketing of cosmetics containing that new cosmetic ingredient.

  Chapter 3: Registration and Filing Management of Cosmetics

  Section 1: General Requirements

  Article 28: Applicants for cosmetic product registration and filers shall meet the following conditions:

  (1) It is an enterprise or other organization established in accordance with the law;

  (2) Possess a quality management system that is commensurate with the cosmetics for which registration or filing is being sought;

  (3) Possesses the capability for adverse reaction monitoring and evaluation.

  When a registration applicant submits an application for the first time to register a special‑purpose cosmetic, or when a filer submits an application for the first time to file a general‑purpose cosmetic, they shall submit supporting documentation demonstrating compliance with the requirements set forth in the preceding paragraph.

  Article 29: Cosmetic product registrants and filers shall, in accordance with laws, administrative regulations, mandatory national standards, technical specifications, and the provisions on registration and filing management, carry out activities such as cosmetic product research and development, safety assessment, and registration/filing testing, and submit registration and filing documentation in compliance with the relevant requirements for such documentation.

  Article 30: Cosmetic product registrants and filers shall select raw materials that comply with the requirements of laws, administrative regulations, mandatory national standards, and technical specifications for the manufacture of cosmetics, and shall be responsible for the safety of the cosmetic raw materials they use. When applying for registration or filing, cosmetic product registrants and filers shall, through the information service platform, clearly specify the sources of raw materials and relevant information on their safety.

  Article 31: Where a cosmetic product registrant or filer entrusts the production of cosmetics, domestically produced cosmetics shall, at the time of application for registration or filing, have the commissioned production relationship confirmed and linked through the information service platform by the cosmetic manufacturer; for imported cosmetics, the cosmetic product registrant or filer shall submit relevant documentation demonstrating the existence of a commissioned production relationship.

  Article 32: Cosmetic product registrants and filers shall clearly specify the standards applicable to their products and submit such standards to the drug regulatory authority when applying for registration or filing.

  Article 33: Applicants for cosmetic product registration and filers shall entrust qualified testing institutions that meet the requirements for cosmetic product registration and filing inspections to conduct testing in accordance with the provisions of mandatory national standards, technical specifications, and the requirements for registration and filing inspections.

  Section 2: Filing Management

  Article 34: Prior to the marketing or importation of ordinary cosmetics, the filer shall complete the filing process by submitting the required filing materials through the information service platform in accordance with the requirements of the National Medical Products Administration.

  Article 35: For ordinary imported cosmetics that have already been filed, if they are to be imported through a port located outside the administrative region of the province, autonomous region, or municipality directly under the central government where the domestic responsible party is situated, the importer shall, via the information service platform, supplement the submission of information on the import port and the contact details of the person handling customs clearance procedures.

  Article 36: For ordinary cosmetics that have been filed, the product name may not be changed arbitrarily without justifiable reasons; nor may the claimed efficacy be altered arbitrarily in the absence of sufficient scientific evidence.

  Registered ordinary cosmetics may not arbitrarily alter their product formulations, except in cases where minor changes to the formulation result from factors such as a change in the source of raw materials.

  If a change in the address of the filer or the domestic responsible party results in a change of the filing authority, the filer shall re‑file.

  Article 37: The filer of ordinary cosmetics shall, on an annual basis, report to the drug regulatory authority responsible for filing management the status of production and importation, as well as compliance with laws and regulations, mandatory national standards, and technical specifications.

  If a product that has been filed is no longer manufactured or imported, the filer shall promptly report to the drug regulatory authority responsible for filing management to have the filing cancelled.

  Section III Registration Management

  Article 38: Prior to the production or import of special cosmetics, the applicant for registration shall submit the required application materials in accordance with the requirements of the National Medical Products Administration.

  Where the registration procedures and time limits for special cosmetics are not specified, the provisions of these Measures governing the registration of new cosmetic ingredients shall apply.

  Article 39: The technical review agency shall, within 90 working days from the date of receipt of the application materials, organize and conduct the technical review in accordance with the requirements for technical review, and shall take the following actions depending on the circumstances:

  (1) If the application materials are true and complete, and can demonstrate the product’s safety and controllable quality, as well as the reasonableness of its formulation and the standards it complies with, and if they meet the requirements of applicable laws, administrative regulations, mandatory national standards, and technical specifications, a favorable technical review conclusion shall be issued.

  (2) If the application materials are false and fail to demonstrate the product’s safety and controllable quality, or if the product formulation and the standards under which the product is manufactured are unreasonable, or otherwise do not comply with applicable laws, administrative regulations, mandatory national standards, and technical specifications, a negative technical review conclusion shall be issued.

  (3) Where supplementary information is required from the applicant, all such requirements shall be communicated in a single notice. The applicant shall submit all requested supplementary materials in one submission within 90 working days; upon receipt of the supplementary materials, the technical review agency shall restart the review period. If the supplementary materials are not submitted within the prescribed time limit, the technical review agency shall issue a conclusion that the technical review has not been passed.

  Article 40: Within twenty working days from the date of receipt of the technical review conclusion, the National Medical Products Administration shall review the legality, compliance, and completeness of the technical review procedures and conclusions, and make a decision on whether to grant registration.

  The accepting authority shall, within 10 working days from the date the National Medical Products Administration makes its administrative approval decision, issue to the applicant either a cosmetic product registration certificate or a decision of non-registration. The cosmetic product registration certificate is valid for a period of five years.

  Article 41: Where changes occur to the registration particulars of a registered special‑purpose cosmetic, the National Medical Products Administration shall implement categorized management based on the extent to which such changes affect the product’s safety and efficacy.

  (1) Where changes occur to matters that do not involve safety or efficacy claims, the registrant shall promptly file a record with the National Medical Products Administration.

  (2) Where there are changes affecting safety, or where substantial changes occur in the manufacturing process or in efficacy claims, the registrant shall submit an application for product registration amendment to the National Medical Products Administration.

  (3) If the product name, formulation, or other relevant details change in such a way that the product is, in substance, a new product, the registrant shall reapply for registration.

  Article 42: Where a registered product is no longer manufactured or imported, the registrant shall proactively apply for the cancellation of the registration certificate.

  Section 4: Renewal of Registration Certificate

  Article 43: Where the validity period of a special cosmetics registration certificate is due to expire and an extension is required, the registrant shall submit an application for renewal between 90 and 30 working days prior to the expiration date, and shall undertake to comply with the requirements of mandatory national standards and technical specifications. The registrant shall be responsible for the authenticity and legality of the submitted materials and the commitments made.

  If an application for renewal of registration is not submitted by the deadline, the application will no longer be accepted.

  Article 44: The accepting authority shall, within five working days of receiving a renewal registration application, conduct a formal review of the submitted documents. If the application meets the requirements, it shall be accepted, and a new registration certificate shall be issued to the applicant within ten working days from the date of acceptance. The validity period of the new registration certificate shall be recalculated starting from the day following the expiration of the original registration certificate.

  Article 45: The drug regulatory authority shall supervise the submission materials and commitments pertaining to special cosmetics whose registration has been renewed. If, upon inspection or technical review, it is found that such products fail to comply with mandatory national standards or technical specifications, the registration certificate for the special cosmetic shall be revoked in accordance with the law.

  Chapter Four: Supervision and Management

  Article 46: In accordance with applicable laws and regulations, the drug regulatory authority shall conduct supervision and inspection of the registration and filing activities of registrants and filers. When necessary, it may extend its inspections to entities involved in such registration and filing activities. Relevant entities and individuals shall cooperate and may not refuse inspection or conceal pertinent information.

  Article 47: During the technical review process for registration, the technical review agency may, as necessary, notify the inspection and verification agency to conduct on-site inspections. On-site inspections conducted within China shall be completed within 45 working days, while on-site inspections conducted outside China shall be carried out in accordance with the relevant provisions governing overseas inspections. The time spent on on-site inspections shall not be counted toward the review deadline.

  The applicant for registration shall cooperate with on-site inspection activities and, where sampling and testing are required, shall provide samples in accordance with the relevant requirements.

  Article 48: After a special cosmetic product has obtained its registration certificate, the registrant shall, prior to placing the product on the market, upload images of the product’s label to the information service platform for public access.

  Article 49: Cosmetic product registration certificates may not be transferred. Where the original registrant’s legal status is terminated due to statutory reasons such as corporate merger or division, and the registrant is changed to a newly established enterprise or other organization, an application for amendment of the registration shall be submitted in accordance with the provisions of these Measures.

  The registrant following the change shall comply with the provisions of these Measures pertaining to registrants and shall assume responsibility for the quality and safety of products already on the market.

  Article 50: In light of advances in scientific research that lead to revised understandings of the safety of cosmetics and cosmetic ingredients, or where evidence indicates that cosmetics or cosmetic ingredients may be defective, the drug regulatory authority responsible for registration and filing may order the registrant or filer of the cosmetic or new cosmetic ingredient to conduct a reassessment of safety, or may itself organize relevant raw material manufacturers and cosmetic enterprises to carry out such a reassessment.

  If the re‑evaluation concludes that a cosmetic product or its raw material cannot be deemed safe, the original registration authority shall revoke the registration, and the filing authority shall cancel the filing. Furthermore, the State Council’s drug regulatory authority shall include the relevant cosmetic raw material in the list of ingredients prohibited for use in cosmetic production and publicly announce such inclusion.

  Article 51: In light of developments in scientific research and the monitoring and evaluation of cosmetic safety risks, if a safety risk is identified with a cosmetic ingredient that can be mitigated by establishing specific usage limits and conditions, the scope and conditions for restricted use of such ingredient shall be clearly specified in the Catalogue of Cosmetic Ingredients Already in Use.

  Article 52: Where the drug regulatory authority responsible for registration and filing management is unable to establish contact with the registrant, filer, or domestic responsible party through the registration or filing information, it may designate such parties as key entities subject to enhanced supervision on the information service platform and publicly announce this designation via the same platform.

  Article 53: The drug regulatory authority shall implement risk-based classification and tiered management based on factors such as the operation of the quality management systems of filers, domestic responsible parties, and cosmetic manufacturers, post‑filing supervision, and post‑market inspection and oversight.

  Article 54: The drug regulatory authorities, technical review bodies, on-site inspection agencies, testing institutions, and their staff shall strictly comply with laws, regulations, rules, and the relevant provisions of the National Medical Products Administration, ensuring that all related work is conducted in a scientific, objective, and impartial manner.

  Article 55: Without the consent of the registrant or filer, the drug regulatory authority, specialized technical institutions and their staff, as well as personnel involved in the review and assessment, shall not disclose any trade secrets, undisclosed information, or confidential business information submitted by the registrant or filer, unless otherwise provided by law or where such disclosure is necessary for national security or the protection of significant public interests.

  Chapter Five: Legal Liability

  Article 56: If the registrant of a cosmetic or a new cosmetic ingredient fails to apply for a change of registration in accordance with these Measures, the original drug regulatory authority that issued the registration certificate shall order it to make corrections, issue a warning, and impose a fine of no less than RMB 10,000 but no more than RMB 30,000.

  If the filer of a cosmetic product or a new cosmetic ingredient fails to update the filing information for ordinary cosmetics or new cosmetic ingredients in accordance with these Measures, the drug regulatory authority responsible for filing management shall order rectification, issue a warning, and impose a fine of no less than RMB 5,000 and no more than RMB 30,000.

  If the registrant of a cosmetic product or a new cosmetic ingredient fails to re-register in accordance with the provisions of these Measures, penalties shall be imposed pursuant to Article 59 of the Regulations on the Supervision and Administration of Cosmetics; if the filer of a cosmetic product or a new cosmetic ingredient fails to re-file in accordance with the provisions of these Measures, penalties shall be imposed pursuant to Paragraph 1 of Article 61 of the Regulations on the Supervision and Administration of Cosmetics.

  Article 57: Where the registrant or filer of a new cosmetic ingredient violates the provisions of Article 21 of these Measures, the drug regulatory authority of the province, autonomous region, or municipality directly under the central government shall order it to make corrections; if it refuses to do so, it shall be subject to a fine of no less than RMB 5,000 and no more than RMB 30,000.

  Article 58: If the drug regulatory authority responsible for filing and record‑keeping finds that the filing materials for cosmetics or new cosmetic ingredients do not comply with the relevant requirements, it shall order the party concerned to make corrections within a specified time limit. Where the non‑compliance relates to the safety of the cosmetics or new cosmetic ingredients, the authority may, at the same time, order a suspension of their sale and use.

  For cosmetics and new cosmetic ingredients that have been filed but whose filing information has not yet been made public, if the drug regulatory authority responsible for filing management finds that the submitted documentation does not comply with the requirements, it may order the filer to make corrections and, upon compliance, publish the filing information to the public.

  Article 59: Where the filer falls under any of the following circumstances, the drug regulatory authority responsible for filing management shall revoke the registration of the cosmetic product or the new cosmetic ingredient:

  (1) Submitting false information during the filing process;

  (2) Where the filed documentation does not comply with the requirements and has not been rectified within the prescribed time limit as required, or where the sale or use of cosmetics or new cosmetic ingredients has not been suspended as required;

  (3) Not falling within the scope of new cosmetic ingredients or cosmetic product filing.

  Chapter VI Supplementary Provisions

  Article 60: With respect to time limits related to the issuance of registration acceptance notices, the notification of technical review opinions, the issuance of registration certificates, the publication of filing information, registration re-examination, and the submission of reports on the use of new cosmetic ingredients, the relevant time shall be determined by the date of submission or dispatch through the information service platform.

  Article 61: Cosmetics whose final manufacturing step involving direct contact with the product is carried out within China shall be deemed domestically produced; those manufactured outside China shall be deemed imported; and those manufactured in Taiwan, Hong Kong, or Macao shall be subject to import‑product regulations.

  For products that are registered or filed under a single product name and are intended for combined use or packaged as a set, if the final manufacturing step in which the product comes into direct contact with its contents is performed outside China, such products shall be regulated as imported products.

  Article 62: After cosmetics and new cosmetic ingredients have obtained registration or completed filing, they shall be assigned identification numbers in accordance with the following rules.

  (1) Rules for the registration number of new cosmetic ingredients: “Guozhuang Yuan Bei Zi” followed by a four-digit year code and a sequential number indicating the order of newly registered cosmetic ingredients for the current year.

  (2) Registration numbering rules for new cosmetic ingredients: “Guozhuangyuanzhuzi” followed by a four-digit year code and a sequential number indicating the order of registration for new cosmetic ingredients in that year.

  (3) Rules for the filing number of ordinary cosmetics:

  Domestic products: Abbreviation of the province, autonomous region, or municipality directly under the central government + GZwangwang filing number + four-digit year + sequential number of the product filed within the administrative region for the current year;

  Imported products: National Cosmetics Filing Number (with the abbreviation of the province, autonomous region, or municipality directly under the central government where the domestic responsible party is located) + a four-digit year code + the sequential number of the product filed nationwide for the current year.

  Products from Taiwan, Hong Kong, and Macao of China: National Cosmetics Filing Number—composed of the abbreviation of the province, autonomous region, or municipality directly under the central government where the domestic responsible party is located, followed by a four-digit year code and a sequential number for products filed nationwide in the current year.

  (4) Rules for the Registration Numbers of Special-Use Cosmetics:

  Domestic products: “Guozhuang Tezi” followed by a four-digit year code and a sequential registration number for the current year.

  Imported products: National Cosmetics Special Import Approval Code + four-digit year code + sequential registration number for the current year;

  Products from Taiwan, Hong Kong, and Macao: “Guozhuang Tezhi” followed by a four-digit year code and a sequential registration number for the current year.

  Article 63 This Measures shall come into force on May 1, 2021.

Source: China Detergent Industry Information Network